ArticleAorta (Stamford, Conn.)2026
Frozen Elephant Trunk versus Ascyrus Medical Dissection Stent in Acute Type A Aortic Dissection: Choosing the Appropriate Arch Strategy.
Article in Aorta (Stamford, Conn.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abstract: Optimal management of the aortic arch during repair of acute type A aortic dissection remains debated. Hemiarch repair can achieve acceptable early survival, but persistent false lumen perfusion and residual distal dissection may contribute to later distal aortic enlargement or reintervention in a subset of patients. The frozen elephant trunk (FET) technique aims to improve distal aortic remodeling by covering intimal tears, expanding the true lumen, and promoting false lumen thrombosis, but it adds operative complexity because it requires more extensive arch reconstruction and supra-aortic vessel management. The Ascyrus Medical Dissection Stent (AMDS), an uncovered nitinol stent, has emerged as an adjunct to hemiarch repair. It is intended to reduce distal anastomotic new entry tears, support true lumen expansion, and facilitate distal aortic stabilization without formal total arch replacement. Contemporary evidence from the DARTS and PERSEVERE studies and observational series suggests that FET and AMDS may serve different operative goals in selected patients, although their roles are overlapping rather than mutually exclusive. FET may be more suitable when more extensive distal arch or proximal descending aortic pathology is present, whereas AMDS may be considered when a less extensive arch procedure is desired in the setting of arch instability or malperfusion. Neither approach should be viewed as universally superior. Instead, strategy should be individualized on the basis of patient age, intimal tear location, malperfusion status, operative risk, and institutional experience. AMDS may represent an additional option in selected high-risk patients.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.